Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials Cannabis Investing News
Hemispherx to Distribute Second Lot of Ampligen for use in Multiple Indications in Argentina, the United States and Europe Pharmaceutical Investing
Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia Pharmaceutical Investing
Canntab Signs Collaboration and Profit Sharing Agreement with FSD Pharma for Production and Market of Oral Dose Delivery Platforms Cannabis Investing News
FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma Biotech Investing
New Independent Data Further Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) Over Surrogate Measurements Medical Device Investing
argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia Biotech Investing
Therma Bright Adds Strategic Advisor, Too Jae Min, Professor, Department of Anesthesiology and Pain Medicine, Korea University Cannabis Investing News
Isodiol International Inc. Announces Partnership with Powerhouse Gym as Preferred CBD Vendor with Iso-Sport Cannabis Investing News
